2023-2024 Regular SessionDelaware Legislature

HB302: An Act To Amend Title 18 Of The Delaware Code Relating To Prostate Cancer Screening.

Legislative Summary

According to the American Cancer Society, prostate cancer is the second-leading cause of death from cancer in men. It is estimated that about 1 in 41 men will die of prostate cancer. According to ZERO Prostate Cancer, Black men face serious health care disparities regarding prostate cancer. 1 in 6 Black men will develop prostate cancer in their lifetime compared to 1 in 8 men overall. Black men are also 1.7 times more likely to be diagnosed with, and 2.1 times more likely to die from, prostate cancer than white men.

Demographic Impact

Overall analysis of equity impact

80% Positive
High ConfidenceView detailed demographic breakdown ↓

Unlock Full Demographic Insights

Go beyond the overall score.

Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.

Enable full analysis features for your organization.

Contact Sales to Learn More

Or email us directly at sales@legiequity.us.

Bill History

4/11/2024
was introduced and adopted in lieu of HB 302
5/7/2024
Passed By House. Votes: 24 YES 3 NO 8 NOT VOTING 6 ABSENT
5/7/2024
Assigned to Banking, Business, Insurance & Technology Committee in Senate
5/22/2024
Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 6 On Its Merits
6/20/2024
Passed By Senate. Votes: 18 YES 3 ABSENT
10/28/2024
Signed by Governor

Roll Call Votes

Senate Third Reading
6/20/2024
18
Yea
0
Nay
0
Not Voting
3
Absent
Result: PASSED
House Third Reading
5/7/2024
24
Yea
3
Nay
8
Not Voting
6
Absent
Result: PASSED